Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 14/20 | 0.51 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.47 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.47 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
| ▸ | TBXA2R | P21731 | 5/20 | 0.42 |
| ▸ | NAMPT | P43490 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8442527 | 0.89 | ALDH1A1 (0.49) | TBXAS1TDP1TBXA2R | |
| SCHEMBL8442980 | 0.81 | MMP2 (0.47) | — | |
| SCHEMBL8441482 | 0.81 | ALDH1A1 (0.50) | TBXAS1TBXA2R | |
| SCHEMBL8440592 | 0.81 | ALDH1A1 (0.59) | TDP1 | |
| SCHEMBL8437964 | 0.81 | L3MBTL1 (0.53) | — | |
| SCHEMBL8437801 | 0.79 | ALDH1A1 (0.57) | TBXAS1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL8440906 | 0.78 | ALDH1A1 (0.58) | — | |
| SCHEMBL8443157 | 0.78 | MEP1B (0.49) | TBXA2R | |
| SCHEMBL8438771 | 0.78 | KMT2A (0.53) | SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL8520794 | 0.77 | TBXAS1 (0.50) | TBXAS1SLC1A3SLC1A2SLC1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5955505-A | TREATING NERVE DEGENERATIVE DISORDERS | NIPPON SUISAN KAISHA, LTD. (JP) | 1999-09-21 | — | — | US | disclosed |